Clinical Trials Directory

Trials / Unknown

UnknownNCT03042091

Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery

Combined Mechanical and Oral Antibiotic Bowel Preparation Versus Oral Antibiotics Alone for the Reduction of Surgical Site Infection Following Elective Colorectal Resection

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
224 (estimated)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This randomized clinical trial studies how well neomycin and metronidazole hydrochloride with or without polyethylene glycol work in reducing infection in patients undergoing elective colorectal surgery. Polyethylene glycol, may draw water from the body into the colon, flushing out the contents of the colon. Antibiotics, like neomycin and metronidazole hydrochloride, may stop bacteria from growing. It is not yet known whether it's better to give preoperative neomycin and metronidazole hydrochloride with or without polyethylene glycol in reducing surgical site infection after colorectal surgery.

Detailed description

PRIMARY OBJECTIVES: I. To estimate the difference in rates of surgical site infection following elective colorectal resections in patients given a preoperative mechanical bowel prep with oral antibiotics as compared to preoperative oral antibiotics alone. SECONDARY OBJECTIVES: I. To determine rates of post-operative clostridium difficile infection, adynamic ileus, cardiopulmonary complications, urinary tract infection, length of stay and mortality in patients given preoperative oral antibiotics with a mechanical bowel prep versus preoperative antibiotics alone.

Conditions

Interventions

TypeNameDescription
DRUGPolyethylene GlycolGiven orally
DRUGNeomycinGiven orally
DRUGMetronidazole HydrochlorideGiven orally
PROCEDURETherapeutic Conventional SurgeryUndergo colorectal resection

Timeline

Start date
2016-09-01
Primary completion
2020-10-01
Completion
2021-10-01
First posted
2017-02-03
Last updated
2018-08-22

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03042091. Inclusion in this directory is not an endorsement.